ABL DIAGNOSTICS (EPA:ABLD) | WebDisclosure

Basculer en Français

10895	Companies
237216	Keywords
166116	Articles
127349	Press releases

Home
Companies
ABL DIAGNOSTICS

PRESS RELEASE

published on 06/12/2026 at 08:00, 2 months 15 days ago

Informations privilégiées / Autres communiqués
ABL Diagnostics et CDL Pharma remportent un contrat international pluriannuel de 2,7 M€ jusqu'en 2031 avec un laboratoire pharmaceutique européen, renforçant ainsi leurs activités dans les services à valeur ajoutée liés à la recherche clinique internationale

Recherche Clinique Maladies Neurodégénératives Contrat International ABL Diagnostics CDL Pharma
PRESS RELEASE

published on 06/12/2026 at 08:00, 2 months 15 days ago

Inside Information / Other news releases
ABL Diagnostics and CDL Pharma secure a multi-year international contract of up to €2.7 million through 2031. The contract involves services for neurodegenerative disease clinical programs across North America, Europe, and Asia

Neurodegenerative Diseases ABL Diagnostics Multi-year Contract CDL Pharma International Clinical Program
BRIEF

published on 06/10/2026 at 00:05, 2 months 18 days ago

ABL Diagnostics : Informations sur les droits de vote et le capital

Euronext Paris Droits De Vote Actions Nominatives Biologie Moléculaire Capital Social ABL
BRIEF

published on 06/10/2026 at 00:05, 2 months 18 days ago

ABL Diagnostics Discloses Voting and Share Information

Euronext Paris Share Capital Voting Rights Molecular Biology Double Voting
BRIEF

published on 06/10/2026 at 00:05, 2 months 18 days ago

ABL Diagnostics: Information on voting rights and capital

Euronext Paris Voting Rights Registered Shares Molecular Biology ABL Share Capital
BRIEF

published on 06/10/2026 at 00:05, 2 months 18 days ago

ABL Diagnostics divulgue des informations sur le vote et les actions

Euronext Paris Capital Social Droit De Vote Biologie Moléculaire Double Vote
PRESS RELEASE

published on 06/10/2026 at 00:00, 2 months 18 days ago

Terms of availability of the preparatory documents for the GM
ABL Diagnostics (ABLD) discloses information on total voting rights and share capital composition as per regulatory requirements. The company specializes in molecular biology tests and global solutions for academic labs, private labs, and researchers

Share Capital Voting Rights Regulatory Disclosure ABL Diagnostics Molecular Biology Tests
PRESS RELEASE

published on 06/10/2026 at 00:00, 2 months 18 days ago

Modalités de mise à disposition des documents préparatoires à l'AG
ABL Diagnostics (ABLD) est une société internationale spécialisée dans les tests de biologie moléculaire innovants. Son siège est à Woippy. Elle est cotée sur Euronext Paris

Euronext Paris Biologie Moléculaire ABL Diagnostics Innovants Woippy
BRIEF

published on 06/09/2026 at 19:05, 2 months 18 days ago

ABL Diagnostics annonce la tenue de son assemblée générale le 30 juin 2026.

Actionnaires Paris Assemblée Générale États Financiers Diagnostics ABL
BRIEF

published on 06/09/2026 at 19:05, 2 months 18 days ago

ABL Diagnostics is preparing for its General Assembly on June 30, 2026

Investors General Assembly Preparatory Documents Molecular Biology ABL Diagnostics

Accesswire

Published on 08/28/2026 at 04:30, 1 hour 1 minute ago

Snipp Interactive Reports Q2 2026 Financial Results; Returns to Positive EBITDA on Highest Quarterly Revenue in Five Quarters
Published on 08/27/2026 at 23:05, 6 hours 26 minutes ago

Galway Metals Announces Filing of NI 43-101 Technical Report for Updated Clarence Stream Mineral Resource Estimate
Published on 08/27/2026 at 22:35, 6 hours 56 minutes ago

Spirit Blockchain Capital Inc. Announces Shares for Services Issuance and Provides Technology Commercialization Update
Published on 08/27/2026 at 22:25, 7 hours 6 minutes ago

Vanta Announces Engagement of Independent Trading Group for Market-Making Services to Support Strategic Capital Markets Initiatives
Published on 08/27/2026 at 16:30, 13 hours 1 minute ago

TDM Financial Retained for Investor Awareness Services

View all ACCESSWIRE

EQS Group

Published on 08/27/2026 at 20:40, 8 hours 51 minutes ago

Once Human Now Available on PS5 and XBOX
Published on 08/27/2026 at 19:34, 9 hours 57 minutes ago

Halfords Group PLC: Holding in Company
Published on 08/27/2026 at 19:15, 10 hours 16 minutes ago

China Hongqiao Wins Asia Responsible Enterprise Awards for Third Consecutive Year
Published on 08/27/2026 at 19:15, 10 hours 16 minutes ago

China Hongqiao distinguée pour la troisième année consécutive aux « Asia Responsible Enterprise Awards », ses pratiques en matière d'économie circulaire à nouveau reconnues à l'international
Published on 08/27/2026 at 18:36, 10 hours 55 minutes ago

Haier Smart Home Reports H1 2026 Results: Q2 Revenue Grows Year-on-Year; Net Profit Improves Quarter-on-Quarter

Les Echos

Published on 08/26/2026 at 18:02, 1 day 11 hours ago

Altareit: Altarea press release regarding the Primonial matter
Published on 08/26/2026 at 18:02, 1 day 11 hours ago

Altareit : Communiqué de presse d’Altarea relatif au dossier Primonial
Published on 08/26/2026 at 18:00, 1 day 11 hours ago

Altarea: Comprehensive settlement agreement reached, ending the dispute between Altarea and the shareholders of the Praemia group (formerly Primonial group)
Published on 08/26/2026 at 18:00, 1 day 11 hours ago

Altarea : Conclusion d’un accord global mettant fin au litige entre Altarea et les actionnaires du groupe Praemia (ex-groupe Primonial)
Published on 08/26/2026 at 18:00, 1 day 11 hours ago

KLARSEN : lance Dimea, sa nouvelle activité e-commerce dédiée aux compléments alimentaires

View all LES ECHOS COMFI WIRE